Sebastian Pomplun

Affiliations: 
Massachusetts Institute of Technology, Cambridge, MA, United States 
Area:
Bioorganic chemistry, combinatorial drug discovery, chemical biology,
Google:
"Sebastian Pomplun"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Ellenbroek BD, Kahler JP, Arella D, et al. (2024) Development of DuoMYC: a synthetic cell penetrant miniprotein that efficiently inhibits the oncogenic transcription factor MYC. Angewandte Chemie (International Ed. in English). e202416082
Charalampidou A, Nehls T, Meyners C, et al. (2024) Automated Flow Peptide Synthesis Enables Engineering of Proteins with Stabilized Transient Binding Pockets. Acs Central Science. 10: 649-657
Stransky F, Kostrz D, Follenfant M, et al. (2024) Use of DNA forceps to measure receptor-ligand dissociation equilibrium constants in a single-molecule competition assay. Methods in Enzymology. 694: 51-82
Ellenbroek BD, Kahler JP, Evers SR, et al. (2024) Synthetic Peptides: Promising Modalities for the Targeting of Disease-Related Nucleic Acids. Angewandte Chemie (International Ed. in English). e202401704
Kolos JM, Pomplun S, Jung S, et al. (2021) Picomolar FKBP inhibitors enabled by a single water-displacing methyl group in bicyclic [4.3.1] aza-amides. Chemical Science. 12: 14758-14765
Pomplun S, Jbara M, Schissel CK, et al. (2021) Parallel Automated Flow Synthesis of Covalent Protein Complexes That Can Inhibit MYC-Driven Transcription. Acs Central Science. 7: 1408-1418
Jbara M, Pomplun S, Schissel CK, et al. (2021) Engineering Bioactive Dimeric Transcription Factor Analogs via Palladium Rebound Reagents. Journal of the American Chemical Society
Pomplun S, Jbara M, Quartararo AJ, et al. (2021) Discovery of High-Affinity Peptide Binders for the SARS-CoV-2 Spike Protein. Acs Central Science. 7: 156-163
Pomplun S. (2021) Targeting the SARS-CoV-2-spike protein: from antibodies to miniproteins and peptides Rsc Medicinal Chemistry. 12: 197-202
Pomplun S. (2020) Targeting the SARS-CoV-2-spike protein: from antibodies to miniproteins and peptides. Rsc Medicinal Chemistry. 12: 197-202
See more...